Published online May 6, 2020. doi: 10.12998/wjcc.v8.i9.1729
Peer-review started: December 23, 2019
First decision: February 20, 2020
Revised: March 15, 2020
Accepted: April 10, 2020
Article in press: April 10, 2020
Published online: May 6, 2020
Processing time: 130 Days and 3.8 Hours
Intrapancreatic accessory spleen (IPAS) mimics a pancreatic neoplasm on imaging studies, and due to the lack of radiological diagnostic criteria, patients undergo unnecessary distal pancreatectomies. Endoscopic ultrasonography (EUS) is a reliable and efficient diagnostic modality for pancreatic diseases. However, no EUS criteria have been established for IPAS. We present the EUS-elastography image of IPAS, which may minimize the chance of misdiagnosis in the future.
A 50-year-old man was referred for an EUS evaluation after computed tomography showed a hypervascular enhanced mass in the tail of the pancreas, which indicated a neuroendocrine neoplasm. EUS elastography demonstrated that the lesion of interest covered no more than 25% of the region of interest. The patient underwent distal pancreatectomy. However, the resected tissue was evaluated, and the patient was finally diagnosed with IPAS.
IPAS should be considered in patients with suspected pancreatic neuroendocrine tumors of the pancreatic tail before surgery is performed. The differentiation between IPAS and pancreatic neuroendocrine tumors can be demonstrated using EUS-elastography.
Core tip: We report the case of a patient with intrapancreatic accessory spleen evaluated by endoscopic ultrasonography and endoscopic ultrasonography elastography. We present the endoscopic ultrasound-elastography features of intrapancreatic accessory spleen, which may help to minimize the chance of misdiagnosis and prevent patients from undergoing unnecessary surgery in the future.